David H. Deming
At a glance: David H. Deming is Director at Phio Pharmaceuticals (PHIO). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $6K. On file: 2 purchase lines ($10K) and 0 sale lines ($0).
Disclosed holdings: about $38K of PHIO stock: 49,800 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 13, 2026 close of $0.77. This counts only PHIO shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Phio Pharmaceuticals Corp. (PHIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | PHIOPhio Pharmaceuticals Corp.First buy | Buy | 6,80044,600 held (+18%) | $0.84 | $6K | -8.2% |
| Nov 12SEC | PHIOPhio Pharmaceuticals Corp.First buy | Buy | 5,20049,800 held (+12%) | $0.84 | $4K | -8.0% |
- Buy
Director David H Deming bought $6K of PHIO at $0.84 — first open-market purchase in our records.
Follow David H. Deming
Get one email when David H. Deming files a new purchase or sale. Free.
At most one email a day about David H. Deming, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.